Zi Yang

Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization

Mice Heterozygous for a Defect in Mitochondrial Trifunctional Protein Develop Hepatic Steatosis and Insulin Resistance

Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications

Pregnancy-Related Liver Disorders

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy

Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta

Animal Models of Preeclampsia

Fetal genotypes and pregnancy outcomes in 35 families with mitochondrial trifunctional protein mutations

Differences in Liver Injury and Trophoblastic Mitochondrial Damage in Different Preeclampsia-like Mouse Models

Different Effects of Pravastatin on Preeclampsia-like Symptoms in Different Mouse Models

Risk factors for gestational diabetes mellitus in Chinese women—a prospective study of 16 286 pregnant women in China

Inhibition of nitric oxide synthase lowers fatty acid oxidation in preeclampsia-like mice at early gestational stage.

Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model